Pinned Tweet
After 14 wonderful years at @BrighamWomens, @MassGenBrigham, @DanaFarber, and @VABostonHC, I am happy to announce that I will be the Director of @MountSinaiHeart at @MountSinaiNYC and the Dr. Valentin Fuster Professor of CV Medicine at @IcahnMountSinai. mountsinai.org/about/newsroo…
See our recap of the hottest trials at #AHA26 during the @ACCinTouch Cardiology Hour! #cardiology #cardiovascular #cardiotwitter #cardioX @AHAScience @AHAMeetings
Mount Sinai was proud to support the ACC Cardiology Hour at #ScientificSessions26. Led by Valentin Fuster, MD, PhD, MACC, and joined by @DLBHATTMD, a panel of experts engaged in an insightful discussion of some of the meeting’s key late-breaking trials. The panel went beyond the trial results to consider their implications for clinical practice and future research.
Watch the episode here: mshs.co/48WhPsy
@MountSinaiHeart @ACCinTouch @JACCJournals @AHAScience @American_Heart
#CardioX #Cardiology #Research
17
1,334
Dr. Deepak L. Bhatt retweeted
🤝@GoHealio caught up with @DLBHATTMD of @MountSinaiHeart at @ScientificSessions26 to discuss the late-breaking science from @American_Heart's meeting.
Stay tuned for his expert perspective on HORIZON-Lp(a) and more!❤️
Dr. Deepak L. Bhatt retweeted
📚 The November issue is out now! Read here: hubs.ly/Q04DQcw90
@DLBHATTMD @murugiah_k @Dr_JHAnderson @PradyAgasthiMD @AgstamSourabh @mohanedegred @NeerajShahMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
Dr. Deepak L. Bhatt retweeted
See our recap of what was hot at #AHA26! #cardiology #cardioX #cardiovascular #cardiotwitter @MountSinaiHeart @CleClinicHVTI @umichCVC @ACCinTouch @ACCmediacenter
🎥 New ACC Cardiology Hour!
Valentin Fuster, MD, PhD, MACC, and a panel of experts discuss the key late-breaking trials from #ScientificSessions26, including ZEUS, Lp(a)HORIZON, HORIZON Outcomes & more.
Watch the video ➡️ bit.ly/3Umnncw @DLBHATTMD #CardioX
Dr. Deepak L. Bhatt retweeted
Replying to @NicholasChiuMD
9/9 🤝
Fantastic collaboration with my longtime friend @RahulAggarwalMD and an outstanding team @AklElie, @AndrewOseran, @HFpEF, @DLBHATTMD, @rkwadhera, and @girish_nadkarni
🔗 Full study: jacc.org/doi/10.1016/j.jacc.…
Dr. Deepak L. Bhatt retweeted
Congratulations to @NancyatHeart and the planning committee on a spectacular @American_Heart meeting in Chicago - as well as bringing the festive Diwali spirit to the AHA reception! #AHA26 #cardiology #cardioX @manesh_patelMD @HeartBobH @AHANewYorkCity
See our recap of what was hot at #AHA26! #cardiology #cardioX #cardiovascular #cardiotwitter @MountSinaiHeart @CleClinicHVTI @umichCVC @ACCinTouch @ACCmediacenter
🎥 New ACC Cardiology Hour!
Valentin Fuster, MD, PhD, MACC, and a panel of experts discuss the key late-breaking trials from #ScientificSessions26, including ZEUS, Lp(a)HORIZON, HORIZON Outcomes & more.
Watch the video ➡️ bit.ly/3Umnncw @DLBHATTMD #CardioX
Congratulations to @NancyatHeart and the planning committee on a spectacular @American_Heart meeting in Chicago - as well as bringing the festive Diwali spirit to the AHA reception! #AHA26 #cardiology #cardioX @manesh_patelMD @HeartBobH @AHANewYorkCity
📚 The November issue is out now! Read here: hubs.ly/Q04DQcw90
@DLBHATTMD @murugiah_k @Dr_JHAnderson @PradyAgasthiMD @AgstamSourabh @mohanedegred @NeerajShahMD #cardioTwitter #cardioX #cardiology #interventionalcardiology
Replying to @NicholasChiuMD
9/9 🤝
Fantastic collaboration with my longtime friend @RahulAggarwalMD and an outstanding team @AklElie, @AndrewOseran, @HFpEF, @DLBHATTMD, @rkwadhera, and @girish_nadkarni
🔗 Full study: jacc.org/doi/10.1016/j.jacc.…
🤝@GoHealio caught up with @DLBHATTMD of @MountSinaiHeart at @ScientificSessions26 to discuss the late-breaking science from @American_Heart's meeting.
Stay tuned for his expert perspective on HORIZON-Lp(a) and more!❤️
How should lp(a) be used to guide #CV_prevention in the absence of benefit of lp(a)-lowering ?
Read our debate paper in @ESC_Journals #EJPC
@DLBHATTMD @AboyansV @EAPCPresident @vass_vassiliou @gbiondizoccai
17
1,380
Dr. Deepak L. Bhatt retweeted
From breakthrough research in acute coronary syndromes to innovations in coronary artery disease and cardiovascular-kidney-metabolic health, hear from @DLBHATTMD at #ScientificSessions26.
@AHAScience @IcahnMountSinai
#CardioX #Cardiology
✅Lp(a) at the #AHA26 - no 💊 pharma yet on the HORIZON. So should we still screen it ? Does Knowing Lp(a) Change What We Do? See the debate in #EJPC ⤵️ academic.oup.com/eurjpc/arti…
@escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic @GalTsaban @DLBHATTMD
Kicking off #AHA2026 with these amazing colleagues. Awaiting full results of HORIZON and ZEUS.@BudoffMd @DLBHATTMD Leslie Cho.
What we know from Lp(a)HORIZON and what remains unknown
The Lp(a)HORIZON trial is a landmark study whose negative primary endpoint result must be interpreted with the precision the underlying science demands. The causal role of Lp(a), the ability to lower Lp(a) pharmacologically, and the clinical benefit of that reduction are distinct propositions, and only the third is directly tested by this trial.
@DLBHATTMD @DrMarthaGulati @hvanspall @CMichaelGibson
sciencedirect.com/science/ar…
Dr. Deepak L. Bhatt retweeted
Some thoughts about HORIZON as we await the formal data at #AHA26. #cardiology #cardiovascular #prevention #cardiotwitter #cardioX
Lp(a)HORIZON was negative. But what exactly did it disprove?
Not that Lp(a) is causal.
Not that we can lower it.
It challenged whether pharmacologic lowering reduces events.
The full data with component outcomes, precision, subgroup analyses, and timing will determine what comes next.
New viewpoint in @PCVDJournal
@AbdelazizMD1 @DLBHATTMD @ElsevierConnect
sciencedirect.com/science/ar…
From breakthrough research in acute coronary syndromes to innovations in coronary artery disease and cardiovascular-kidney-metabolic health, hear from @DLBHATTMD at #ScientificSessions26.
@AHAScience @IcahnMountSinai
#CardioX #Cardiology
Some thoughts about HORIZON as we await the formal data at #AHA26. #cardiology #cardiovascular #prevention #cardiotwitter #cardioX
Lp(a)HORIZON was negative. But what exactly did it disprove?
Not that Lp(a) is causal.
Not that we can lower it.
It challenged whether pharmacologic lowering reduces events.
The full data with component outcomes, precision, subgroup analyses, and timing will determine what comes next.
New viewpoint in @PCVDJournal
@AbdelazizMD1 @DLBHATTMD @ElsevierConnect
sciencedirect.com/science/ar…

























